The aurora kinase inhibitor, CCT137690, triggered the necroptosis of pancreatic cancer cells by RIPK1, RIPK3, and MLKL, and hindered the growth of in situ pancreatic tumors in mice [50]. This evidence concerns the gene RIPK3 and familial pancreatic carcinoma.